Viswanadhapalli, S., Ma, S., Sareddy, G. R., Lee, T., Li, M., Gilbreath, C., . . . Vadlamudi, R. K. (2019). Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers. Breast Cancer Res.
Chicago Style CitationViswanadhapalli, Suryavathi, et al. "Estrogen Receptor Coregulator Binding Modulator (ERX-11) Enhances the Activity of CDK4/6 Inhibitors against Estrogen Receptor-positive Breast Cancers." Breast Cancer Res 2019.
Cita MLAViswanadhapalli, Suryavathi, et al. "Estrogen Receptor Coregulator Binding Modulator (ERX-11) Enhances the Activity of CDK4/6 Inhibitors against Estrogen Receptor-positive Breast Cancers." Breast Cancer Res 2019.
Atenció: Aquestes cites poden no estar 100% correctes.